IO Biotech, Inc. (IOBT)
$0.00Close
SELLCRISIS · day 46
Key stats
- Market cap
- $0
- Beta
- 0.89
- P/E (TTM)
- -0.02
- 1M
- -100.00%
- vs SPY 1M
- -102.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on IOBT?
- LOPJLB’s latest quantitative signal on IO Biotech, Inc. (IOBT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IOBT in?
- IO Biotech, Inc. (IOBT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does IO Biotech, Inc. (IOBT) do?
- IO Biotech, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating immune-modulating cancer treatments. These therapies leverage its proprietary T-win technology platform. The company's primary investigational drug, IO102-IO103, is engineered to counteract immunosuppressive proteins such as Indoleamine 2,3-dehydrogenase (IDO) and programmed death-ligand (PD-L1). This candidate is…